Fundamental Analysis Stories
Are Exagen (USA Stocks:XGN) unfluctuating technical and fundamental indicators contributing to the recent decline?
![]() | 2 days ago at Macroaxis By Ellen Johnson |
- XGN Exagen Inc
- XGN 3.65 -0.1
- Low 3.44
- High 3.79
- Alpha -0.35
- Beta -1.69
- Return On Equity -0.94
- Return On Asset -0.17
- Profit Margin (0.27) %
- Operating Margin (0.25) %
- Current Valuation 65.76 M
- Shares Outstanding 17.9 M
- Shares Owned By Insiders 27.64 %
- Shares Owned By Institutions 54.26 %
- Number Of Shares Shorted 32.45 K
- Price To Book 6.79 X
- Price To Sales 1.16 X
- Revenue 55.64 M
- Gross Profit 33.11 M
- EBITDA (11.14 M)
- Net Income (15.12 M)
- Cash And Equivalents 76.39 M
- Cash Per Share 4.70 X
- Total Debt 3.18 M
- Debt To Equity 0.55 %
- Current Ratio 9.30 X
- Book Value Per Share 0.54 X
- Cash Flow From Operations (13.28 M)
- Short Ratio 0.17 X
- Earnings Per Share (0.83) X
- Target Price 6.75
- Number Of Employees 11
- Beta 1.4
- Market Capitalization 64.79 M
- Total Asset 44.69 M
- Retained Earnings (294.33 M)
- Working Capital 22.95 M
- Net Asset 44.69 M
- Accumulation Distribution 0.0923
- Daily Balance Of Power (0.29)
- Rate Of Daily Change 0.97
- Day Median Price 3.62
- Day Typical Price 3.63
- Market Facilitation Index 0.35
- Price Action Indicator (0.01)
- Period Momentum Indicator (0.10)
- Relative Strength Index 46.92
Reviewed by Vlad Skutelnik
3 days ago at Macroaxis By Raphi Shpitalnik | ![]() |
few days ago at Macroaxis By Vlad Skutelnik | ![]() |
Key Takeaways
You can use the Campbell Soup advice module to verify current investment recommendations from analysts assessing the company's growth potential. This involves examining fundamental and technical market data.over two weeks ago at Macroaxis By Ellen Johnson | ![]() |
over two weeks ago at Macroaxis By Rifka Kats | ![]() |
Main Points
Considering Manulife Financial's robust cash flow from operations of 20.42B and a favorable debt-to-equity ratio of 0.43%, the stock appears to offer solid value, making it a compelling buy for investors seeking stability in the insurance sector.over three weeks ago at Macroaxis By Rifka Kats | ![]() |
In high-growth tech sectors such as artificial intelligence (AI), financial technology (fintech), and biotechnology, identifying the next unicorn startup—defined as a privately held company valued at over $1 billion—is both an art and a science. Venture capitalists (VCs) play a crucial role in funding and nurturing these startups, employing sophisticated valuation techniques to forecast their potential for exponential growth.
Founders, aspiring entrepreneurs, and even retail investors must be familiar with VCs' methods for evaluating startups in disruptive industries. These methods include analyzing critical factors such as market size, scalability, and founder experience. By understanding these methods, founders and small investors can align their strategies with VC-backed ventures and improve their odds of success.
over a month ago at Macroaxis By Aina Ster | ![]() |
over a month ago at Macroaxis By Gabriel Shpitalnik | ![]() |
over a month ago at Macroaxis By Aina Ster | ![]() |
over a month ago at Macroaxis By Raphi Shpitalnik | ![]() |